Walking Fish Therapeutics Launches with $50 Million in Series A Financing to Accelerate Development of B Cell Therapies for Multiple Diseases

from Venture Capital Access Online: Latest Venture Capital and Private Equity News https://ift.tt/2YIUrhp
via IFTTT